Effects of phosphorylation of P-glycoprotein on multidrug resistance - PubMed (original) (raw)

Review

Effects of phosphorylation of P-glycoprotein on multidrug resistance

U A Germann et al. J Bioenerg Biomembr. 1995 Feb.

Abstract

Cells expressing elevated levels of the membrane phosphoprotein P-glycoprotein exhibit a multidrug resistance phenotype. Studies involving protein kinase activators and inhibitors have implied that covalent modification of P-glycoprotein by phosphorylation may modulate its biological activity as a multidrug transporter. Most of these reagents, however, have additional mechanisms of action and may alter drug accumulation within multidrug resistant cells independent of, or in addition to, their effects on the state of phosphorylation of P-glycoprotein. The protein kinase(s) responsible for P-glycoprotein phosphorylation has(ve) not been unambiguously identified, although several possible candidates have been suggested. Recent biochemical analyses demonstrate that the major sites of phosphorylation are clustered within the linker region that connects the two homologous halves of P-glycoprotein. Mutational analyses have been initiated to confirm this finding. Preliminary data obtained from phosphorylation- and dephosphorylation-defective mutants suggest that phosphorylation of P-glycoprotein is not essential to confer multidrug resistance.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Leuk Res. 1985;9(7):885-95 - PubMed
    1. Cancer Res. 1987 Jan 15;47(2):433-41 - PubMed
    1. Biochim Biophys Acta. 1992 Jul 7;1139(3):169-83 - PubMed
    1. Cancer Res. 1989 Dec 1;49(23):6634-9 - PubMed
    1. Biochim Biophys Acta. 1977 Jun 2;467(2):238-50 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources